Benchmark Investment Advisors LLC Pfizer Inc Transaction History

Benchmark Investment Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $184,190 - $239,243	7,049 New	7,049 $202,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $705,640 - $816,409	-19,536 Reduced 65.69%	10,204 $374,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $26,391 - $34,357	-670 Reduced 2.2%	29,740 $1.21 Million
Q4 2022 Feb 21, 2023	SELL	$41.75 - $54.5 $564,042 - $736,295	-13,510 Reduced 30.76%	30,410 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.42 Million - $1.73 Million	32,387 Added 280.82%	43,920 $1.92 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $159,551 - $189,177	3,429 Added 42.31%	11,533 $605,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $370,758 - $459,415	8,104 New	8,104 $420,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Benchmark Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Benchmark Investment Advisors LLC with notifications on news.